title: Itch and liver: management in primary care.
authors.affiliation: Institute of Cellular Medicine, Newcastle University and Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
authors.forename: Vinod S
authors.initials: VS
authors.lastname: Hegade
authors.affiliation: GlaxoSmithKline Research and Development, Stevenage and Cambridge University Hospitals NHS Foundation Trust, Cambridge.
authors.forename: Stuart F W
authors.initials: SF
authors.lastname: Kendrick
authors.affiliation: Westcliffe Medical Practice, Bradford.
authors.forename: Jahangir
authors.initials: J
authors.lastname: Rehman
authors.affiliation: Institute of Cellular Medicine, Newcastle University and Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
authors.forename: David E J
authors.initials: DE
authors.lastname: Jones
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002779:Cholestasis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000503:physiopathology*; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008111:Liver Function Tests / Q000379:methods*; D008297:Male; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D011537:Pruritus / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D002792:Cholestyramine Resin; D000469:Alkaline Phosphatase; D012293:Rifampin